ELAB
Elevai Labs, Inc. Common Stock
NASDAQ: ELAB · HEALTHCARE · BIOTECHNOLOGY
$2.53
-0.39% today
Updated 2026-04-29
Market cap
$11.08M
P/E ratio
—
P/S ratio
18.78x
EPS (TTM)
$-382.61
Dividend yield
—
52W range
$2 – $269
Volume
9.0M
Elevai Labs, Inc. Common Stock (ELAB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $17022.00 | $666250.00 | $1.89M | $5.19M | $8.99M |
| Cash & equivalents | $13351.00 | $411858.00 | $1.15M | $3.33M | $3.98M |
| Current assets | $17022.00 | $636525.00 | $1.55M | $4.92M | $6.05M |
| Total liabilities | $40611.00 | $215622.00 | $760873.00 | $1.36M | $2.33M |
| Current liabilities | $40611.00 | $215622.00 | $588272.00 | $1.30M | $1.80M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | $-23589.00 | $450628.00 | $1.13M | $3.83M | $6.66M |
| Retained earnings | $-137366.00 | $-922105.00 | $-2.72M | $-7.02M | $-13.27M |
| Accounts receivable | $371.00 | $1710.00 | $12854.00 | $36161.00 | $5276.00 |
| Inventory | — | $160817.00 | $230145.00 | $495667.00 | $1044.00 |
| Goodwill | — | — | — | — | — |